The Medicines and Healthcare Products Regulatory Agency (MHRA) has for the first time approved the use of a dual (ICS/beta-agonist) combination treatment to be prescribed as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an

To consider how and when we use FeNO testing, we need to go to the definition of asthma. Both BTS/SIGN1 and GINA2 define it as a predominantly inflammatory disorder of the airways with airway hyperresponsiveness and variability in symptoms.

The common chronic respiratory disorders diagnosed in primary care—asthma and chronic obstructive pulmonary disease (COPD)—are both characterised by airway obstruction.

Asthma is a long-term condition characterised for the vast majority by trigger induced eosinophilic airway inflammation resulting in wheeze, breathlessness, cough, and chest tightness.

In this PCRS Podcast episode, Carol Stonham (Primary Care Nurse and PCRS Policy Lead) is in conversation with Amanda Roberts (PCRS Patient Reference Group and PCRS Education Committee Patient Representative) to delve into the positive and negative aspects of Amanda's asthma reviews of the past, d

This week the BBC reported on the results of laboratory tests conducted on vapes confiscated from a school in Kidderminster.

In this one hour live webinar we will cover:

Originally presented at the PCRS Respiratory Conference 2020 Dr Glenis Scadding presents One airway: if they're wheezing, are they sneezing too?

March 2023 saw the first approval of a combination inhaled corticosteroid + long-acting beta2-agonist inhaler for the management of mild asthma in people over 12 years of age. The approval supports the move away from reliance on short-acting beta2-agonists which fa

Vaping can successfully help people address their tobacco dependence and reduce the long-term threats to their health from tobacco use.

There is still no sign of varenicline (Champix), a medication that can reduce nicotine cravings and help people quit smoking, 18 months after its approval was withdrawn in the UK due to concerns about impurities.

Pulmonary rehabilitation (PR) improves quality of life and reduces exacerbations and NICE guidelines recommend that PR should be offered to all patients who consider themselves functionally disabled due to their COPD.

This week the Health Minister Neil O’Brien announced the formation of a new “illicit vapes enforcement squad” – led by Trading Standards and backed by £3 million of government funding to tackle rising levels of youth vaping.

In the final podcast of the PCRS One Airway, One disease series we focus on the treatment of allergic rhinitis and real-life application using British and European guidelines.

In this one hour live webinar we will cover: